TrialAnnals of nuclear medicine2026

Long-term efficacy and safety of peptide receptor radionuclide therapy in Japanese patients with unresectable neuroendocrine tumor: extension of the Japanese phase I and phase I/II study.

Noritoshi Kobayashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.